Customize this page|
0
Votes
vote
Early Phase II clinical trial for RK-023 to treat androgenetic alopeciaR-Tech Ueno, Ltd. has started early Phase II clinical trial for RK-023, a physiologically active fatty acid derivative developed by the company -- a new compound targeted as a treatment for androgenetic alopecia (male pattern baldness). ... |
United States
You are in 
Choose your city Change
Choose your city Change
22
Nov
-
14°
73% now -
Today
11° -
Mon
24° / 28° -
Tue
28° / 33°
Feeds with all content in English
About Keegy
Blog
Help
Contact
Who
Webmasters
Suggest a feed
Statistics
Contents belongs to their owners with their original licenses.
- South America
-
Argentina
• Bolivia
• Brazil
• Chile
• Colombia
• Ecuador
• Paraguay
• Peru
• Uruguay
• Venezuela
- Central America
- Costa Rica • Cuba • El Salvador • Guatemala • Honduras • Nicaragua • Panama • Puerto Rico • Rep. Dominicana
- North America
- Canada • Mexico • United States • US en español
- Europe
-
Spain
• France
• Italy
• Portugal
• United Kingdom
- Other countries
- India • Australia